Northwestern Mutual Wealth Management Co. Has $65.82 Million Stake in CME Group Inc. $CME

Northwestern Mutual Wealth Management Co. increased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 1,777.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 241,023 shares of the financial services provider’s stock after purchasing an additional 228,187 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in CME Group were worth $65,819,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in CME. Sanders Capital LLC acquired a new position in CME Group during the third quarter worth $1,006,932,000. Strive Asset Management LLC acquired a new stake in CME Group in the third quarter valued at $636,487,000. Mawer Investment Management Ltd. grew its position in shares of CME Group by 107.2% in the 3rd quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider’s stock valued at $406,029,000 after acquiring an additional 777,571 shares during the period. Viking Global Investors LP bought a new position in shares of CME Group in the 2nd quarter valued at about $164,648,000. Finally, Vanguard Group Inc. grew its position in shares of CME Group by 1.7% in the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock valued at $9,802,366,000 after acquiring an additional 588,509 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

NASDAQ CME opened at $298.86 on Monday. The firm has a 50-day moving average of $298.07 and a 200-day moving average of $288.18. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $108.29 billion, a PE ratio of 25.50, a P/E/G ratio of 3.61 and a beta of 0.23. CME Group Inc. has a 52-week low of $257.17 and a 52-week high of $329.16.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. CME Group’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the company posted $2.80 EPS. On average, sell-side analysts anticipate that CME Group Inc. will post 12.26 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is currently 44.37%.

Analyst Ratings Changes

A number of research analysts have recently commented on CME shares. UBS Group reissued a “neutral” rating and issued a $310.00 price objective on shares of CME Group in a research report on Friday, February 6th. Raymond James Financial lifted their price objective on shares of CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research report on Monday, April 6th. Weiss Ratings raised shares of CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Monday, March 2nd. Piper Sandler lifted their price objective on shares of CME Group from $313.00 to $329.00 and gave the company an “overweight” rating in a research report on Wednesday, April 15th. Finally, Keefe, Bruyette & Woods started coverage on shares of CME Group in a research report on Wednesday, April 8th. They issued a “market perform” rating and a $305.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $305.29.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group announced plans to launch Nasdaq CME Crypto Index futures on June 8, pending regulatory review. The new contract would be CME’s first-ever market-cap weighted futures product and expands its regulated crypto offerings, which investors may view as a growth driver. Article: CME Group to Launch Nasdaq CME Crypto Index Futures
• Positive Sentiment: Reports that Interactive Brokers is integrating CME event contracts into a unified prediction-markets platform highlight CME’s growing relevance in new trading products and could support longer-term volume opportunities. Article: Interactive Brokers Debuts All-in-One Prediction Market Portal
• Positive Sentiment: Coverage of CME’s annual meeting preliminary results was routine governance news, but it showed no apparent disruption to the company’s leadership or shareholder base. Article: CME Group Inc. Announces Preliminary Results of 2026 Annual Meeting
• Neutral Sentiment: Multiple reports said CME and Intercontinental Exchange are lobbying U.S. regulators to increase scrutiny of Hyperliquid, arguing that the unregulated platform could affect price discovery in oil and crypto markets. This is more about competitive/regulatory positioning than a direct business event for CME, but it may be seen as CME defending the regulated futures ecosystem. Article: CME, ICE Push US to Curb Crypto’s Offshore Oil Trading Upstart
• Neutral Sentiment: Broader market commentary referenced CME’s FedWatch tool showing higher odds of a Fed hike later in 2026, but this is an indirect macro signal rather than company-specific news. Article: The Bond Market Just Fired A Warning Shot At The AI Rally — Fed Hike Ahead

Insider Transactions at CME Group

In other news, Director Martin J. Gepsman sold 300 shares of the firm’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the completion of the sale, the director owned 24,999 shares in the company, valued at approximately $7,647,194.10. This trade represents a 1.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Bryan T. Durkin sold 4,200 shares of the firm’s stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the sale, the director owned 43,007 shares of the company’s stock, valued at approximately $13,317,117.55. This represents a 8.90% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 7,791 shares of company stock worth $2,489,421. 0.30% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.